Griseofulvin Dosing
For adults and children over 50 kg, dose griseofulvin at 1 g per day (single or divided dose) for 6–8 weeks; for children under 50 kg, dose at 15–20 mg/kg/day (single or divided dose) for 6–8 weeks, particularly for Microsporum infections. 1
Dosing by Body Weight
Children and Adults
- < 50 kg: 15–20 mg/kg/day (single or divided dose) for 6–8 weeks 1
- > 50 kg: 1 g/day (single or divided dose) for 6–8 weeks 1
The FDA label provides slightly different guidance for adults at 0.5 g daily (500 mg/day), with more severe infections potentially requiring 0.75–1.0 g/day initially, then reduced to 0.5 g after response 2. For pediatric patients over 2 years, the FDA recommends 10 mg/kg/day, though this is lower than current guideline recommendations 2.
Treatment Duration by Infection Site
- Tinea capitis: 4–6 weeks (FDA) 2 or 6–8 weeks (British guidelines) 1
- Tinea corporis: 2–4 weeks 2
- Tinea pedis: 4–8 weeks 2
- Tinea unguium (fingernails): At least 4 months 2
- Tinea unguium (toenails): At least 6 months 2
Critical Considerations for Efficacy
Griseofulvin is significantly more effective against Microsporum species (88.5% response rate) than Trichophyton species (67.9% response rate). 1 For Trichophyton infections, higher doses (up to 25 mg/kg/day) for longer periods (12–18 weeks) may be required 1. Recent evidence from refugee populations suggests that doses up to 30 mg/kg/day may be necessary for resistant Trichophyton violaceum infections 3.
Absorption Enhancement
Take griseofulvin with fatty food to increase absorption and improve bioavailability. 1 This is a critical factor often overlooked that can significantly impact treatment success.
When to Consider Higher Doses
- Resistant cases: Up to 25 mg/kg/day may be necessary 1
- Trichophyton infections: Consider 20–25 mg/kg/day for 8 weeks minimum 4, 5
- Treatment failures: Doses up to 30 mg/kg/day have been used successfully 3
Common Pitfalls to Avoid
- Underdosing: The traditional 10 mg/kg/day is often insufficient; 15–20 mg/kg/day is the current standard 1
- Stopping too early: Continue until mycological cure is achieved, not just clinical improvement 1
- Not taking with food: Absorption is significantly enhanced with fatty meals 1
- Wrong organism: Griseofulvin is inferior to terbinafine for Trichophyton species 6
Treatment Failure Management
If clinical improvement occurs but mycology remains positive, continue therapy for an additional 2–4 weeks 1. If no initial clinical improvement, consider:
- Compliance issues
- Suboptimal drug absorption (ensure taking with fatty food)
- Organism insensitivity (particularly Trichophyton species)
- Reinfection 1
Contraindications and Drug Interactions
Contraindications: Lupus erythematosus, porphyria, severe liver disease 1
Drug interactions:
- Rifampicin decreases plasma concentration
- Cimetidine increases plasma concentration 1
- May reduce efficacy of oral contraceptives 7
Safety Profile
Griseofulvin is well-tolerated, particularly in children. Side effects include gastrointestinal disturbances and rashes in < 8% of patients, with only 0.8% requiring discontinuation 1. Monitoring liver enzymes is generally unnecessary for standard treatment courses 5.